Holding in Company
Cambridge Antibody Tech Group PLC
19 December 2001
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1) Name of company
a. Cambridge Antibody Technology
2) Name of shareholder having a major interest
Fidelity Investments
3) Please state whether notification indicates that it is in respect
of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder if it
is a
holding of that person's spouse or children under the age of 18
Non Beneficial
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them
Chase Nominees Limited (1,040,576), State Street Nominees Limited
(139,600), HSBC (1,110,275), State Street Nominees Ltd.
(4,700),Nortrust Nominees Ltd (123,200), Chase Nominees Ltd (151,820),
RBS Trust Bank (146,400), HSBC (4,310), Northern Trust (155,100), BT
Globenet Nominees Ltd (27,000), Morgan Stanley (49,739), Bankers Trust
(13,300), Bank of New York Europe (14,400), Citibank (6,100), HSBC
Clinet Holdings Nominee (UK) Limited (33,880), Bank of New York -
London(9,000), JP Morgan (1,510), (unspecified) (9,600),Chase Nomiees
Ltd (5,382), Chase Nominees Ltd (189,000), Bankers Trust (183,200),
MSS Nominees Ltd (26,500), Bank of New York Europe (37,700), BT
Globebet Nominees Ltd (7,000)
5) Number of shares/amount of stock acquired
NIL
6) Percentage of issued class
NIL
7) Number of shares/amount of stock disposed
385,525
8) Percentage of issued class
1.084%
9) Class of security
Ordinary 10p Shares
10) Date of transaction
Not disclosed
11) Date company informed
18 December 2001
12) Total holding following this notification
3,489,292
13) Total percentage holding of issued class following this
notification
9.823%
14) Any additional information
None
15) Name of contact and telephone number for queries
Diane Mellett 01763 263233
16) Name and signature of authorised company official responsible for
making this notification
Date of notification 19 December, 2001